The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug ...
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus. HealthDay News — ...
Planning ahead is the best medicine for a quick and healthy recovery from surgery. Learn about the causes and best treatment options for hair loss. Learn the presurgery tips that can help improve ...
Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ...
The FDA has approved Susvimo, which delivers medicine continuously via a surgical implant that can be refilled every six months vs. getting monthly injections. For those with diabetic macular edema ...
Public Service Commissioner Sir Brian Roche fears the sheer number of entities, departments and agencies – some of which are small – creates inefficiencies and duplication.
A look at the current state of AI in diabetic eye disease and where the future may take us. Artificial intelligence (AI) and deep learning tools are now a part of many people’s daily lives, whether ...
The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...
The combination of Topcon's NW500 and AEYE-DS achieved 100% imageability and high diagnostic accuracy, with 92% sensitivity and 90% specificity. Over 99% of participants were successfully imaged on ...
Newleos Therapeutics emerged Thursday with $93.5 million and a bundle of oral small molecules that it licensed from Roche, further demonstrating that the pharma-to-start ...
Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience treatments with several clinical programs from Swiss major Roche in hand.
Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback